Concepedia
Statistics
Publications
9
Citations
362
H-Index
Active since
2000
Affiliations
Mochida Pharmaceutical (Japan)(Current)
Fujisawa City Hospital
Katsue Magari is an author at Mochida Pharmaceutical (Japan) specializing in inflammation, medicine, and rheumatology.
Publications per year
2000–2012
FK506 potently inhibits T cell activation induced TNF‐α and IL‐1β production <i>in vitro</i> by human peripheral blood mononuclear cells
Shozo Sakuma, Yasuko Kato, Fusako Nishigaki et al. · British Journal of Pharmacology · 2000 · 93 citations · Full text
Medicine, Immunology, Pharmacology +17
FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis
Shozo Sakuma, Fusako Nishigaki, Katsue Magari et al. · Inflammation Research · 2001 · 49 citations
Medicine, Immunology, Pharmacology +7
Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro
Shozo Sakuma, Yasuko Kato, Fusako Nishigaki et al. · International Immunopharmacology · 2001 · 45 citations
Medicine, Immunology, Pharmacotherapy +16
Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: Effect of FK506, an inhibitor of T cell activation
Katsue Magari, Shinji Miyata, Y. Ohkubo et al. · Inflammation Research · 2004 · 36 citations
Medicine, Immunology, Pathology +15
Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
Katsue Magari, Susumu Miyata, Fusako Nishigaki et al. · PubMed · 2003 · 36 citations
1–5 of 9